کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2798201 1155682 2008 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Incretin-based therapies in type 2 diabetes: A review of clinical results
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی علوم غدد
پیش نمایش صفحه اول مقاله
Incretin-based therapies in type 2 diabetes: A review of clinical results
چکیده انگلیسی
GLP-1 analogues (incretin mimetics) and DPP-4 inhibitors (incretin enhancers) represent new classes of anti-diabetic agents for the treatment of type 2 diabetes. The efficacy and safety of the incretin mimetic exenatide and of the DPP-4 inhibitors, sitagliptin and vildagliptin, have been clearly demonstrated by a very large number of clinical trials. Efficacy was demonstrated in terms of reduction of HbA1c, fasting and postprandial glucose. Moreover, exenatide showed a favourable effect on weight, while DPP-4 inhibitors were neutral with respect to this outcome. The low rate of hypoglycemic events seen in all studies confirms the glucose dependent action of incretins.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Diabetes Research and Clinical Practice - Volume 82, Supplement 2, 15 December 2008, Pages S102-S107
نویسندگان
, , , , ,